HRV as a Prognostic and Autonomic Marker in Cardiac Disease in Dogs and Cats

Heart rate variability (HRV) is the measure of the beat-to-beat oscillation between consecutive heartbeats and works as a non-invasive window into the autonomic balance of the heart. In cardiac disease in dogs and cats, such as myxomatous mitral valve disease (MMVD) and dilated cardiomyopathy (DCM), disease progression tends to be accompanied by a fall in HRV, reflecting sympathetic predominance over vagal tone. Veterinary studies have linked reduced HRV indices to more advanced stages and to worse outcomes, which makes HRV a useful tool for autonomic assessment and risk stratification. It is always a complement to the clinical exam, the echocardiogram, and the electrocardiogram (ECG), never a standalone diagnosis: the clinical decision always rests with the veterinarian.

What HRV measures in the canine and feline heart

The healthy heart does not beat like a metronome. Between one beat and the next there are small timing variations, governed by the continuous tug-of-war between the sympathetic (accelerator) and parasympathetic or vagal (brake) branches of the autonomic nervous system. When vagal tone predominates, at rest or during sleep, the intervals between beats vary more and HRV is high. When the sympathetic branch takes over, under stress or disease, the intervals become more regular and HRV falls.

In practice, HRV is calculated from the intervals between normal beats (R-R or N-N intervals) extracted from an ECG, ideally from a prolonged Holter recording or from standardized short windows. The indices fall into time domain (such as the standard deviation of normal intervals and beat-to-beat variation measures) and frequency domain (low- and high-frequency bands and the ratio between them, used as a reading of sympathovagal balance). In dogs, the marked respiratory sinus arrhythmia, which is physiological and vagal, is part of the picture and must be considered in interpretation.

A methodological caveat matters: much of the conceptual framework of HRV originated in human cardiology, and cut-off values and the magnitude of indices do not transfer directly to dogs and cats, which have their own autonomic physiology and heart rates. For this reason, the reading here is anchored in evidence generated in animals, and reference values should be those of the laboratory, the species, and the protocol in use.

Reduced HRV and sympathetic activation in MMVD

MMVD is the most common acquired heart disease in the dog. As mitral regurgitation progresses and the left atrium and ventricle become overloaded, the body recruits neurohumoral compensatory mechanisms, with activation of the sympathetic and the renin-angiotensin-aldosterone systems. This sympathetic predominance, which sustains heart rate and output in the short term, translates into a progressively lower HRV.

A cross-sectional veterinary study in untreated dogs, classified by MMVD stages according to the ACVIM guideline, found that time-domain HRV indices decreased with disease severity, with the lowest values in stage C dogs, and that the ratio between the low- and high-frequency bands increased progressively, a sign of a shift in autonomic balance toward the sympathetic side. The same work described a correlation between HRV indices and left atrial enlargement, and suggested that autonomic imbalance may precede clinical signs and cardiomegaly, although the authors stress the need for longitudinal studies.

The practical reading is cautious: a falling HRV in a dog with MMVD is consistent with greater sympathetic activation and with disease advancement, but it does not replace grading by echocardiography and radiography, nor does it alone define the stage or the moment to start or adjust therapy. It adds autonomic context to a picture that continues to be built by the full set of examinations.

HRV in DCM and in feline cardiomyopathies

In DCM, systolic dysfunction and ventricular dilation also trigger chronic sympathetic activation, and affected dogs may show reduced HRV. In a veterinary series of Doberman Pinschers, a breed predisposed to DCM, a clear reduction in HRV appeared mainly in animals with the most severe myocardial failure; in less affected dogs HRV was not clearly reduced, and the authors noted that the dog's own respiratory sinus arrhythmia can make HRV less sensitive and that it added no information beyond echocardiography and Holter for estimating severity. This is a reminder that HRV has limits and variable performance depending on stage and species.

In cats, autonomic assessment is more challenging: heart rate is high, the stress of the hospital environment raises sympathetic tone and shortens the usable recording, and hypertrophic cardiomyopathy (HCM) is the dominant disease. A veterinary study using ambulatory electrocardiography in cats with subclinical HCM analyzed HRV and ectopy, showing that Holter is feasible for characterizing arrhythmias and autonomic modulation in the species; the HRV findings in this population, however, were less straightforward than in dogs and depend heavily on context and protocol, which calls for caution in feline interpretation.

The common denominator is that, in cardiac dogs and cats, HRV reflects the autonomic state and tends to deteriorate with progression, but its value as a marker is greater when read serially, in the same animal and with the same protocol, than as an isolated number compared to a universal cut-off, which for veterinary HRV is not yet established.

How to use HRV in monitoring the chronic cardiac patient

In the chronic cardiac dog and cat, HRV is best used as a trend measure. Reassessments with the same method, in the same animal, help reveal whether autonomic tone is stable or drifting toward sympathetic predominance over follow-up, a piece of data that adds to the resting respiratory rate, serial echocardiography, ECG, and biomarkers in composing the risk picture.

For this reading to be reliable, the recording must be of good quality: predominantly sinus rhythm, exclusion of ectopic beats and artifacts, a standardized time window and, whenever possible, similar conditions across examinations. Frequent arrhythmias, atrial fibrillation, and noise distort the indices, and interpretation must always account for ongoing medication, since several cardiovascular drugs alter autonomic tone.

HRV does not, on its own, establish diagnosis, stage, or prognosis, and it should not trigger changes in management automatically. It is a layer of autonomic information that supports risk stratification and monitoring, within a complete cardiological evaluation. The clinical decision, in all cases, belongs to the responsible veterinarian.

HRV, ECG, and the connected INpulse platform

Every HRV analysis starts from a well-acquired ECG, because the indices depend on precise detection of each beat and on a noise-free tracing. Electrocardiographs such as the INcardio X, integrated into INpulse's connected ecosystem, capture the signal with quality and send it to INcloud, where the patient's history is available for serial reassessments and for telecardiology reporting by cardiologists, supporting exactly the kind of longitudinal monitoring that gives HRV its meaning.

It is worth reinforcing the responsible framing: HRV is a tool for autonomic assessment and to support risk stratification, not a substitute for clinical reasoning. INpulse provides the technology for capture, recording, and reporting; interpretation and management always remain with the veterinarian.